Area of research
Materials Chemistry · Spectroscopy
Research interest
Research interests include Biodistribution, Medicine, Cancer research, Pharmacokinetics, In vivo, and Nuclear medicine.
Neuropilin-1-target self-assembled peptide nanoparticles contribute to tumor treatment by inducing pyroptosis
Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03
Clinical translation of a novel FAPI dimer [68Ga]Ga-LNC1013
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study
Clinical Evaluation of<sup>68</sup>Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α<sub>v</sub>β<sub>3</sub>in Various Cancer Types
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression
Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [<sup>68</sup>Ga]Ga-FAPI-RGD
Novel multifunctional NIR-II aggregation-induced emission nanoparticles-assisted intraoperative identification and elimination of residual tumor
Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics
Nickel‐Catalyzed Directed Benzylation of Ortho C−H Bonds in Aromatic Amides through C−H/C−N Cleavage